hg_163524.1

Basic information about the TSS

---

TSS ID: hg_163524.1 Species: human Chr: chr17		Start: 82458733 End: 82458748 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000309794.16 ENST00000578082.5 Distance: 0 GeneID: 26502 HGNC/MGI_ID: HGNC:29916 UniProt_ID: Q9UHQ1

Gene_name: nuclear prelamin A recognition factor Gene_symbol: NARF Gene_synonyms: DKFZp434G0420 FLJ10067 IOP2 Gene_source: HGNC:29916

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NM_012336
Entrez ID:	26502
Nearest Unigene:	Hs.256526
Nearest Refseq:	NM_012336
Nearest Ensembl:	ENSG00000141562
Gene Name:	nuclear prelamin A recognition factor
Gene Alias:	IOP2
Gene Description:	nuclear prelamin A recognition factor
Gene Type:	protein-coding
CpG%:	0.115
GC%:	0.726368
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NARF p2@NARF p3@NARF
Sample		p1@NARF	p2@NARF	p3@NARF
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	42.47	5.06	11.49
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	40.46	6.88	8.90
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	46.30	6.17	11.57
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	49.48	3.74	8.73
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	47.69	3.82	9.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	49.23	7.75	6.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	61.88	7.63	9.59
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	39.97	4.60	11.63
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	47.45	5.34	11.11
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	76.51	7.54	26.08
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	80.04	2.83	24.66
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	72.77	4.07	23.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.80	26.60	4.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	14.43	22.55	4.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.95	22.39	5.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	15.09	19.62	3.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.76	20.09	4.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.39	22.78	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	18.13	21.86	6.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.79	27.23	4.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	16.97	25.26	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.41	26.07	7.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.25	22.88	3.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.71	19.90	5.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	16.00	21.41	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.83	21.21	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	19.78	25.28	6.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	21.69	27.82	8.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	19.22	22.13	5.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	20.45	27.33	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	20.52	18.63	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	21.69	21.69	5.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.79	24.27	4.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.50	30.51	3.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.01	25.24	6.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.95	28.55	7.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	20.44	24.93	6.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.16	23.78	5.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.18	17.02	4.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.20	22.09	7.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.82	20.94	5.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	23.86	22.54	6.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.82	21.30	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.45	21.85	6.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.27	23.09	6.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.91	17.22	5.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	15.83	13.91	6.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.90	19.08	9.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	19.63	21.30	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.80	18.20	7.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	22.75	23.98	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	24.91	24.02	5.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	41.98	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	24.49	19.87	5.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	24.19	24.85	7.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	43.62	41.11	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	33.98	30.31	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.15	26.25	5.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	14.45	30.19	5.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.15	39.61	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.04	22.56	4.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	16.82	31.96	3.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.85	63.69	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	21.75	29.90	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	18.52	32.17	6.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.62	29.82	6.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	63.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	15.11	3.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.45	14.88	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.20	16.42	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	8.61	35.11	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.50	21.65	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.73	22.32	4.59
Adipocyte - breast, donor1	11376-118A8	3.96	4.28	2.06
Adipocyte - breast, donor2	11327-117E4	5.61	7.70	1.76
Adipocyte - omental, donor1	11473-119C6	3.94	4.33	3.05
Adipocyte - omental, donor2	11474-119C7	5.98	4.48	2.99
Adipocyte - omental, donor3	11475-119C8	7.70	3.68	4.02
Adipocyte - perirenal, donor1	11476-119C9	9.57	5.10	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	2.20	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	9.48	4.06	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	7.12	6.78	7.82
Adipocyte differentiation, day04, donor1	13019-139D4	4.89	6.06	4.11
Adipocyte differentiation, day04, donor2	13022-139D7	7.98	8.49	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	4.18	6.69	2.79
Adipocyte differentiation, day04, donor4	13028-139E4	5.29	4.70	8.82
Adipocyte differentiation, day08, donor1	13020-139D5	6.52	7.40	10.46
Adipocyte differentiation, day08, donor2	13023-139D8	8.39	8.07	5.81
Adipocyte differentiation, day08, donor3	13026-139E2	3.73	3.73	3.20
Adipocyte differentiation, day08, donor4	13029-139E5	5.56	2.23	5.56
Adipocyte differentiation, day12, donor1	13021-139D6	8.32	3.74	14.97
Adipocyte differentiation, day12, donor2	13024-139D9	9.29	7.28	3.52
Adipocyte differentiation, day12, donor3	13027-139E3	5.24	4.58	6.54
Adipocyte differentiation, day12, donor4	13030-139E6	6.39	5.48	5.48
Alveolar Epithelial Cells, donor1	11510-119G7	16.35	10.17	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	15.06	13.63	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	9.58	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	2.52	6.48	5.04
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	18.41	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	3.70	11.92	1.85
Anulus Pulposus Cell, donor1	11248-116E6	4.81	8.70	2.40
Anulus Pulposus Cell, donor2	11463-119B5	2.69	11.76	2.20
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	7.64	2.25
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	4.78	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	4.28	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	6.88	5.98	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	10.12	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	2.64	2.64	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.50	6.50	3.25
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	4.85	8.25	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	6.53	5.34	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5.27	10.17	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	8.71	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	3.76	5.02
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	5.27	6.26	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	6.82	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	3.62	5.43	1.81
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	5.89	5.89	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.29	6.42	2.46
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.61	5.88	2.67
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	7.80	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.48	5.64	2.65
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	7.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.00	6.00	2.57
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.80	11.65	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.07	7.21	3.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	2.42	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.27	6.27	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	2.57	6.63	3.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.13	6.71	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	5.63	5.63	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.14	9.32	2.57
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	8.56	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.68	5.85	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	4.52	10.24	2.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	16.63	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.09	12.21	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	5.86	6.37	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.27	3.81	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.47	5.61	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.87	7.83	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.51	8.12	2.90
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	8.50	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	3.22	7.29	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	4.63	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	6.34	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.15	5.15	2.79
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.02	3.61	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	5.83	3.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	6.21	5.52	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	5.10	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.32	1.78	1.78
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	3.92	7.43	2.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.51	5.20	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.08	10.99	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.54	8.20	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	6.10	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	8.86	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.68	7.94	2.91
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.09	5.82	2.91
Astrocyte - cerebellum, donor1	11500-119F6	7.74	7.25	3.93
Astrocyte - cerebellum, donor2	11580-120F5	6.68	12.32	4.45
Astrocyte - cerebellum, donor3	11661-122F5	14.26	18.25	2.31
Astrocyte - cerebral cortex, donor1	11235-116D2	10.11	12.90	14.64
Astrocyte - cerebral cortex, donor2	11316-117D2	11.32	15.69	9.06
Astrocyte - cerebral cortex, donor3	11392-118C6	7.31	12.83	3.58
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	8.26	21.10	6.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	7.77	20.05	8.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	8.99	20.14	7.97
Basophils, donor1	12241-129G9	13.86	10.20	4.18
Basophils, donor2	12242-129H1	15.15	14.07	11.18
Basophils, donor3	12243-129H2	13.67	7.79	5.29
Bronchial Epithelial Cell, donor1	11511-119G8	6.04	4.74	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	7.31	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.83	11.93	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	12.68	11.65	3.95
Bronchial Epithelial Cell, donor6	11461-119B3	6.91	7.83	4.61
Bronchial Epithelial Cell, donor7	11769-123I5	4.86	9.36	2.52
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.33	6.08	4.53
Burkitt's lymphoma cell line:RAJI	10476-106I8	7.22	9.32	6.06
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	13.43	19.83	17.91
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	10.34
CD14+ Monocytes, donor1	11224-116B9	8.45	10.14	11.27
CD14+ Monocytes, donor2	11305-117B9	10.21	18.00	9.65
CD14+ Monocytes, donor3	11381-118B4	11.85	14.71	7.24
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	8.49	7.08	6.23
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	9.48	10.61	6.07
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.59	6.25	7.89
CD14+ monocytes - mock treated, donor1	11863-125A9	16.04	7.52	7.23
CD14+ monocytes - mock treated, donor2	11873-125C1	12.37	5.13	9.05
CD14+ monocytes - mock treated, donor3	11883-125D2	17.06	9.48	12.08
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.89	3.35	3.35
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.66	4.14	7.18
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	21.82	3.72	7.19
CD14+ monocytes - treated with BCG, donor1	11860-125A6	18.41	4.11	4.50
CD14+ monocytes - treated with BCG, donor2	11870-125B7	21.72	7.30	8.55
CD14+ monocytes - treated with BCG, donor3	11880-125C8	36.13	4.13	10.23
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.33	6.32	2.34
CD14+ monocytes - treated with Candida, donor2	11878-125C6	26.93	5.81	9.50
CD14+ monocytes - treated with Candida, donor3	11888-125D7	46.59	6.66	11.09
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	13.54	6.10	4.76
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	12.57	2.39	9.78
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	26.65	5.00	6.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	14.18	5.72	2.75
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	18.77	3.39	7.24
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	27.50	2.18	6.55
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	28.78	6.46	6.99
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	25.47	9.07	9.77
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	41.66	11.36	15.99
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.66	2.57	2.02
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	15.50	2.11	7.05
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	24.13	1.75	11.41
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	23.02	7.15	3.31
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	24.90	9.66	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	34.49	8.84	11.42
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.88	4.50	4.09
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	17.85	3.25	5.79
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	36.42	2.09	6.26
CD14+CD16+ Monocytes, donor1	11789-124B7	5.89	7.63	10.03
CD14+CD16+ Monocytes, donor2	11801-124D1	7.62	7.62	11.09
CD14+CD16+ Monocytes, donor3	11912-125G4	7.15	7.36	14.95
CD14+CD16- Monocytes, donor1	11788-124B6	11.68	10.59	11.21
CD14+CD16- Monocytes, donor2	11799-124C8	9.78	9.95	7.68
CD14+CD16- Monocytes, donor3	11910-125G2	4.68	10.03	15.38
CD14-CD16+ Monocytes, donor1	11790-124B8	5.36	6.89	14.54
CD14-CD16+ Monocytes, donor2	11800-124C9	6.15	7.47	10.76
CD14-CD16+ Monocytes, donor3	11911-125G3	5.68	8.00	14.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	26.42	18.29
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	9.49	14.92	14.24
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	11.39	14.50	9.32
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	15.99	15.99	15.99
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5.90	25.20	6.43
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	8.42	20.36	16.14
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	9.41	20.39	14.12
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	21.09	3.95
CD19+ B Cells, donor1	11544-120B5	21.37	30.41	21.37
CD19+ B Cells, donor2	11624-122B4	21.76	15.23	12.33
CD19+ B Cells, donor3	11705-123B4	21.20	24.23	16.66
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	711.14	52.12	17.37
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	551.30	40.75	14.78
CD34+ Progenitors, donor1	11545-120B6	76.31	18.07	8.03
CD34+ Progenitors, donor2	11625-122B5	102.81	28.65	15.73
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	30.81	13.53	11.27
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	41.71	17.36	15.11
CD4+ T Cells, donor1	11225-116C1	13.21	17.50	24.64
CD4+ T Cells, donor2	11306-117C1	10.41	21.43	25.72
CD4+ T Cells, donor3	11382-118B5	10.37	15.55	23.18
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	26.80	18.89	18.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	25.38	21.79	20.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.54	22.13	29.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	6.64	23.70	29.39
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	5.62	21.77	26.69
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	16.48	39.55
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	24.71	18.50	14.74
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.71	26.27	16.10
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	26.92	28.37	18.06
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	9.41	19.28	21.07
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	10.13	21.66	20.96
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.48	23.76	22.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	18.13	22.35	18.97
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	18.08	17.66	16.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	17.71	21.38	17.71
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	3.26	17.13	28.55
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.75	19.83	34.30
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	17.93	43.04
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	47.28	27.63	16.13
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	32.06	17.55	18.20
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	21.23	22.28	21.65
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	12.13	15.17	27.30
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	9.10	19.93	22.10
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	6.10	17.00	28.33
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	10.39	22.76	15.84
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	10.16	29.54	20.31
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	4.19	16.75	11.17
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	12.46	24.92	16.62
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	12.51	24.05	16.69
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	6.16	20.02	24.64
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	12.53	23.64	23.28
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	12.46	36.01	23.54
CD8+ T Cells, donor1	11226-116C2	15.39	14.08	27.17
CD8+ T Cells, donor2	11307-117C2	21.78	21.02	26.66
CD8+ T Cells, donor3	11383-118B6	29.54	21.97	22.47
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	18.58	6.65	10.32
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	21.81	4.31	8.15
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	20.52	3.01	6.57
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	24.92	8.11	5.40
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	24.48	5.52	9.84
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	24.56	5.68	6.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	36.50	4.56	10.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	35.27	3.16	6.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	29.08	6.33	7.04
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	36.53	5.43	8.15
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	38.93	4.94	9.59
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	36.77	7.99	5.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	62.60	4.38	10.07
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	61.48	3.64	14.57
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	55.19	7.46	10.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	25.93	2.88	8.64
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	27.91	4.60	8.34
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.75	5.42	8.25
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	28.20	4.12	8.56
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	27.07	6.77	8.61
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	29.81	5.45	8.01
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	25.63	4.21	8.03
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	28.38	2.76	4.73
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	23.45	2.27	8.32
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	76.28	3.21	21.68
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	65.05	9.09	21.68
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	63.11	5.01	24.04
Cardiac Myocyte, donor1	11525-119I4	0.00	7.31	5.48
Cardiac Myocyte, donor2	11605-120I3	2.47	7.41	0.99
Cardiac Myocyte, donor3	11686-122I3	4.74	7.68	1.37
Chondrocyte - de diff, donor1	11261-116G1	2.43	4.51	6.93
Chondrocyte - de diff, donor2	11338-117F6	8.88	4.98	1.78
Chondrocyte - de diff, donor3	11410-118E6	4.89	5.58	2.62
Chondrocyte - re diff, donor2	11339-117F7	19.70	15.22	2.69
Chondrocyte - re diff, donor3	11411-118E7	8.09	11.32	5.26
Ciliary Epithelial Cells, donor1	11242-116D9	7.69	12.51	4.02
Ciliary Epithelial Cells, donor2	11323-117D9	6.20	13.89	5.99
Ciliary Epithelial Cells, donor3	11399-118D4	6.90	12.83	5.58
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	11.83	16.14	20.17
Corneal Epithelial Cells, donor1	11526-119I5	4.61	5.49	3.29
Corneal Epithelial Cells, donor2	11606-120I4	12.51	12.51	4.55
Corneal Epithelial Cells, donor3	11687-122I4	5.88	8.18	3.83
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	13.04	4.62	7.26
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	12.30	8.83	7.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	6.90	10.35
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	11.66	5.72	5.72
Dendritic Cells - plasmacytoid, donor1	11228-116C4	14.01	7.52	21.18
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.75	13.06	19.59
Dendritic Cells - plasmacytoid, donor3	11385-118B8	8.23	15.00	16.94
Endothelial Cells - Aortic, donor0	11207-116A1	29.68	12.01	2.84
Endothelial Cells - Aortic, donor1	11263-116G3	36.97	14.67	5.28
Endothelial Cells - Aortic, donor2	11340-117F8	22.91	12.44	6.79
Endothelial Cells - Aortic, donor3	11412-118E8	22.41	15.33	5.11
Endothelial Cells - Artery, donor1	11264-116G4	16.29	15.42	4.36
Endothelial Cells - Artery, donor2	11341-117F9	26.59	12.94	3.76
Endothelial Cells - Artery, donor3	11413-118E9	23.14	14.38	4.38
Endothelial Cells - Lymphatic, donor1	11236-116D3	47.66	12.63	3.32
Endothelial Cells - Lymphatic, donor2	11317-117D3	40.16	14.30	4.56
Endothelial Cells - Lymphatic, donor3	11393-118C7	38.06	16.91	4.23
Endothelial Cells - Microvascular, donor1	11265-116G5	36.84	10.99	6.83
Endothelial Cells - Microvascular, donor2	11342-117G1	52.07	7.29	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	22.40	15.60	6.52
Endothelial Cells - Thoracic, donor1	11266-116G6	31.21	11.20	6.80
Endothelial Cells - Thoracic, donor2	11343-117G2	27.78	19.92	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	15.16	10.69	8.57
Endothelial Cells - Umbilical vein, donor2	11324-117E1	9.56	15.43	6.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	8.43	12.82	7.82
Endothelial Cells - Vein, donor1	11267-116G7	40.95	12.51	4.55
Endothelial Cells - Vein, donor2	11344-117G3	37.72	9.78	2.10
Endothelial Cells - Vein, donor3	11416-118F3	45.69	30.77	2.67
Eosinophils, donor1	12244-129H3	0.00	15.25	45.74
Eosinophils, donor2	12245-129H4	209.58	74.26	8.25
Eosinophils, donor3	12246-129H5	203.31	32.10	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.38	6.60	1.95
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	4.16	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.44	15.19	3.28
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.61	4.05	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.77	6.72	1.30
Fibroblast - Aortic Adventitial, donor1	11245-116E3	8.49	8.37	2.55
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.96	6.69	3.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	6.33	7.07	1.79
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	8.70	7.90	3.69
Fibroblast - Aortic Adventitial, donor3	11401-118D6	6.64	6.64	1.99
Fibroblast - Cardiac, donor1	11268-116G8	8.17	13.61	1.36
Fibroblast - Cardiac, donor2	11345-117G4	9.10	12.89	3.03
Fibroblast - Cardiac, donor3	11417-118F4	13.88	10.57	1.26
Fibroblast - Cardiac, donor4	11452-119A3	3.03	7.88	3.33
Fibroblast - Cardiac, donor5	11456-119A7	6.35	13.07	1.52
Fibroblast - Cardiac, donor6	11460-119B2	6.37	8.79	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	5.23	10.99	3.89
Fibroblast - Choroid Plexus, donor2	11572-120E6	6.04	14.24	3.88
Fibroblast - Choroid Plexus, donor3	11653-122E6	4.39	13.18	7.32
Fibroblast - Conjunctival, donor1	11531-120A1	4.38	5.30	6.92
Fibroblast - Conjunctival, donor3	11692-122I9	3.22	9.16	2.04
Fibroblast - Dermal, donor1	11269-116G9	2.82	8.45	2.11
Fibroblast - Dermal, donor2	11346-117G5	5.66	8.49	3.77
Fibroblast - Dermal, donor3	11418-118F5	3.26	7.74	2.78
Fibroblast - Dermal, donor4	11450-119A1	5.09	9.72	2.49
Fibroblast - Dermal, donor5	11454-119A5	7.33	6.98	2.97
Fibroblast - Dermal, donor6	11458-119A9	7.15	9.91	3.57
Fibroblast - Gingival, donor1	11237-116D4	1.46	3.33	2.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	2.88	6.03	2.10
Fibroblast - Gingival, donor2	11318-117D4	6.98	13.05	4.61
Fibroblast - Gingival, donor3	11394-118C8	2.42	7.06	2.03
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	0.00	0.00	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	1.41	6.52	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	2.03	3.43	1.87
Fibroblast - Gingival, donor6 (control)	11922-125H5	1.89	3.11	3.38
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	2.47	2.47	8.12
Fibroblast - Gingival, donor7 (control)	11924-125H7	4.24	3.36	6.43
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	3.41	4.09	3.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	6.25	3.84	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	6.16	11.15	2.64
Fibroblast - Lung, donor1	11270-116H1	4.08	6.80	1.36
Fibroblast - Lung, donor2	11347-117G6	5.97	17.91	0.00
Fibroblast - Lung, donor3	11419-118F6	7.18	16.04	3.80
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	0.00	4.17
Fibroblast - Lymphatic, donor2	11586-120G2	0.00	8.39	6.99
Fibroblast - Lymphatic, donor3	11667-122G2	1.12	3.36	3.64
Fibroblast - Mammary, donor1	11540-120B1	4.87	6.90	3.25
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	6.60	7.95	3.30
Fibroblast - Periodontal Ligament, donor2	11319-117D5	4.85	12.13	2.58
Fibroblast - Periodontal Ligament, donor3	11395-118C9	3.98	0.92	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	1.14	3.82	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	2.97	3.51	2.43
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	2.78	4.18	2.09
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.93	7.52	1.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	5.89	5.08	6.30
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	5.35	8.02	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	2.77	8.70	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.32	5.36	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	4.26	6.75	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	5.52	5.32	1.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	6.62	7.52	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	8.10	4.86	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	8.60	11.64	8.35
Fibroblast - skin normal, donor1	11553-120C5	7.06	6.56	4.10
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	5.21	6.62	2.61
Fibroblast - skin normal, donor2	11561-120D4	7.13	7.53	1.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9.97	10.88	4.23
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	6.88	7.04	1.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	4.96	9.06	3.25
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	5.91	9.85	5.25
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	8.42	8.63	2.88
Fibroblast - skin walker warburg, donor1	11554-120C6	11.13	5.06	1.52
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	8.78	10.51	1.88
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	17.43	20.92	13.07
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.40	4.68	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	9.63	5.73	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6.90	2.04	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	30.62	17.61	6.12
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	41.47	19.78	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	44.50	43.07	5.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	15.17	54.05	19.30
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.74	38.36	11.87
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	23.97	42.40	9.51
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.80	46.52	22.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	33.92	30.01	15.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	43.78	34.05	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.13	27.13	4.80
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	20.32	22.04	6.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	18.27	16.39	5.91
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	18.96	24.04	7.31
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	21.04	22.98	4.71
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.69	12.60	3.66
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	18.48	22.59	5.93
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.80	29.27	3.86
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	14.43	19.89	2.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.89	28.07	5.61
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	18.76	28.93	6.20
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	13.85	21.45	2.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	14.92	26.41	6.25
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	23.92	35.96	8.99
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	20.75	15.87	4.97
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.50	25.08	7.49
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	12.98	21.52	5.29
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.82	34.30	6.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.46	19.30	4.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.62	18.58	5.72
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	17.12	32.60	7.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	18.22	41.97	6.11
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	18.84	24.68	5.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.89	28.44	8.16
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	14.02	37.02	7.63
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	19.61	28.85	6.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	12.51	33.68	5.45
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	24.92	35.63	4.83
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.46	21.67	3.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	17.03	31.63	9.12
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.27	37.32	7.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	16.47	23.49	6.59
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.60	27.49	9.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	16.02	21.67	12.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	13.10	22.46	7.49
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	16.98	14.08	9.64
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.60	20.34	9.20
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.45	20.33	7.05
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.62	20.46	9.59
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.45	17.76	7.90
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	10.91	31.74	8.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	13.59	18.86	8.71
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.92	17.55	3.43
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	13.22	17.54	5.34
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	31.45	16.32	3.98
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	20.49	22.19	4.93
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	25.37	33.14	9.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	38.49	15.65	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	32.78	15.82	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	24.44	16.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	9.90	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.13	19.34	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	40.11	11.23	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	8.69	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.20	18.88	2.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	25.94	22.65	3.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	16.66	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	22.37	22.93	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	19.94	21.90	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	16.78	28.52	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	22.58	27.67	2.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	22.08	20.38	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	14.62	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.62	34.93	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.69	24.86	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	20.33	15.25	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	37.69	31.89	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	26.93	23.01	2.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	31.61	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	18.07	23.06	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	17.60	23.14	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.05	36.12	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	15.41	33.90	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	21.57	25.33	5.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	7.45	17.39	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	15.10	53.79	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	13.88	35.61	4.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	13.73	35.61	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.17	42.68	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	11.84	30.09	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	25.97	29.51	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	15.17	36.76	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	10.97	28.53	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.89	38.15	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	19.10	21.49	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	31.54	21.35	4.85
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	5.71	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8.32	3.33	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	4.50	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	2.85	5.39	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.09	4.60	3.34
Hep-2 cells mock treated, biol_rep1	11898-125E8	25.30	8.59	8.82
Hep-2 cells mock treated, biol_rep2	11899-125E9	30.22	6.58	7.93
Hep-2 cells mock treated, biol_rep3	11900-125F1	23.66	8.65	9.78
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	27.11	7.00	7.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.94	6.45	6.02
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	20.67	7.10	7.97
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	22.91	7.22	6.60
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	19.04	5.15	4.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	24.35	4.81	7.05
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	35.26	19.59	7.28
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	27.27	19.91	2.60
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	7.93	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.59	7.41	6.70
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	5.09	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.72	8.92	2.97
Hepatocyte, donor1	11523-119I2	36.32	8.47	9.68
Hepatocyte, donor2	11603-120I1	76.49	7.54	17.24
Hepatocyte, donor3	11684-122I1	14.72	9.20	4.91
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	46.99	53.52	13.71
Intestinal epithelial cells (polarized), donor1	11246-116E4	34.61	5.42	11.36
Iris Pigment Epithelial Cells, donor1	11530-119I9	7.27	11.66	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	127.36	9.55	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	140.18	26.70	26.70
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	134.28	13.84	12.46
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	175.19	30.03	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	142.42	0.00	35.60
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	97.39	20.50	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	164.55	27.42	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	110.45	8.12	19.49
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	120.05	20.01	8.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	145.22	25.41	10.89
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	146.91	19.85	26.47
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	117.52	13.30	7.76
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	172.86	20.95	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	120.30	16.38	11.34
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	128.37	17.01	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	142.13	16.15	15.50
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	119.13	19.32	11.27
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	138.53	14.67	21.19
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	136.02	13.43	13.43
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	129.35	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	138.23	12.06	16.07
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	134.80	17.54	8.31
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	165.89	15.08	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	121.31	13.22	11.33
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	131.51	14.51	8.16
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	29.48	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	131.29	12.91	19.37
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	148.64	13.98	15.25
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	49.29	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	132.64	14.03	17.86
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	145.81	16.40	14.58
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	128.53	14.28	13.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	126.10	6.64	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	120.38	16.36	13.89
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	91.31	12.29	14.05
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	154.01	12.57	12.57
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	117.52	12.52	22.95
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	128.36	13.28	19.92
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	136.16	19.45	25.94
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	107.25	14.82	21.80
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	96.74	27.00	15.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	101.05	13.94	17.42
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	113.08	11.73	24.54
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	92.82	11.08	11.08
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	96.89	14.25	22.80
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	139.90	14.73	12.89
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	69.58	39.33	18.15
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	155.22	12.42	24.83
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	114.20	20.09	19.03
Keratinocyte - epidermal, donor1	11272-116H3	4.24	2.69	1.06
Keratinocyte - epidermal, donor2	11349-117G8	2.93	0.59	2.93
Keratinocyte - epidermal, donor3	11421-118F8	4.64	6.15	1.61
Keratinocyte - oral, donor1	11251-116E9	5.45	10.44	3.97
Keratocytes, donor1	11527-119I6	3.44	4.13	5.50
Keratocytes, donor2	11607-120I5	2.34	4.69	0.00
Keratocytes, donor3	11688-122I5	3.36	14.23	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	17.58	8.79
Lens Epithelial Cells, donor1	11529-119I8	11.87	16.18	2.16
Lens Epithelial Cells, donor2	11609-120I7	13.26	25.14	1.15
Lens Epithelial Cells, donor3	11690-122I7	5.75	7.47	3.63
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	19.57	10.91	2.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	19.81	8.09	5.86
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	31.80	14.48	6.45
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	18.28	12.91	2.69
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	21.43	8.19	3.78
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	23.72	12.94	5.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	18.47	11.49	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	20.98	14.16	5.31
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.35	12.39	5.35
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	17.40	5.93	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.01	11.25	5.43
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	33.33	12.40	5.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.47	10.45	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	20.75	10.73	6.20
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	31.45	10.16	4.12
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.40	6.78	3.08
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.07	9.98	4.05
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	28.36	13.72	5.31
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.10	7.90	3.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.94	9.37	5.56
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	43.06	12.70	3.73
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.09	5.82	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	23.43	8.08	4.85
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	34.21	15.29	4.54
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	15.03	8.81	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	23.45	8.38	4.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	30.53	14.44	5.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.20	4.82	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.44	7.71	7.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	27.67	13.04	3.07
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	19.87	4.36	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.51	8.60	4.63
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	25.03	12.27	3.47
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.25	15.18	3.70
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.77	7.41	4.69
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.06	12.92	2.89
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.22	7.08	4.50
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	23.13	8.22	6.09
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	26.59	13.02	2.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.93	8.89	2.13
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	18.91	7.27	5.33
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	30.97	14.16	3.11
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	20.05	10.39	4.30
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	22.87	10.45	6.86
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	33.43	12.24	4.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.53	9.16	1.98
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	20.75	10.25	6.40
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.06	14.02	4.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	6.80	9.06
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	29.15	14.58	11.51
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	29.69	8.91	8.91
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	28.35	6.77	11.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	17.58	9.14	10.55
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	35.49	6.54	10.27
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	18.03	4.64	9.79
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	9.52	14.27
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	29.86	4.98	7.92
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	21.23	4.65	9.31
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.31	6.75	5.40
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.79	8.13	11.25
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	35.43	11.81	12.32
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	19.76	9.53	7.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	14.66	8.00	6.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	20.88	7.64	14.26
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	22.41	6.67	13.61
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	27.02	10.20	8.12
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	32.52	7.98	11.66
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	26.09	9.79	17.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	18.74	8.95	8.75
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	24.94	5.89	4.76
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	23.70	8.24	13.39
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.93	7.55	8.42
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.34	5.68	10.46
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	21.58	8.30	11.62
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	23.33	8.48	8.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.55	6.64	8.85
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	25.33	6.91	9.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	31.85	4.99	9.59
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.34	7.36	11.32
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	4.10	7.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.72	4.07	9.94
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.83	7.18	5.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	19.42	9.71	11.20
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	31.59	5.57	8.18
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	26.28	6.46	6.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.98	8.56	5.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	19.66	6.66	5.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	25.94	7.24	10.86
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	6.40	8.53
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	24.75	4.81	8.25
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.79	5.90	7.51
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.83	5.39	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	27.78	4.82	5.56
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	31.40	10.47	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	6.35	7.40
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	31.21	6.80	4.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.07	10.18	15.99
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	33.73	8.43	11.50
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.14	10.85	10.85
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	20.70	8.47	10.35
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	31.68	10.56	12.57
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	23.43	9.01	10.81
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	3.44	10.33
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	22.71	10.69	16.92
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	24.63	7.43	8.21
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	31.01	3.30	7.92
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	33.73	9.34	9.86
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	29.75	10.06	12.25
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	27.96	8.39	11.18
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	25.62	6.62	12.81
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.14	7.71	11.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.79	7.60	4.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	25.47	9.61	12.50
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.44	8.35	9.54
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.05	5.47	9.11
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.28	4.84	8.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	26.22	7.98	10.64
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	30.99	7.75	7.75
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	30.23	4.23	9.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.04	8.87	6.97
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	26.65	6.93	7.46
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	35.63	8.05	9.19
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	30.85	8.23	4.63
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.88	8.49	7.78
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.89	5.67	10.78
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.04	6.24	9.15
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	29.76	9.40	7.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	23.80	9.19	4.59
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	20.44	7.90	5.11
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.77	6.02	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	40.10	3.21	4.81
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	33.94	6.87	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	24.78	7.34	7.34
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	40.90	1.78	6.22
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	30.77	5.70	3.99
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	31.44	4.60	5.37
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	38.85	3.28	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	29.84	7.13	5.35
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	43.93	5.98	4.42
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	38.46	2.65	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	49.89	8.31	6.24
Macrophage - monocyte derived, donor1	11232-116C8	7.75	5.70	3.87
Macrophage - monocyte derived, donor2	11313-117C8	3.85	1.28	4.59
Macrophage - monocyte derived, donor3	11389-118C3	7.21	6.03	5.24
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.31	3.19	0.00
Mallassez-derived cells, donor2	11929-125I3	6.34	5.23	1.27
Mallassez-derived cells, donor3	11930-125I4	11.26	6.25	1.39
Mammary Epithelial Cell, donor1	11273-116H4	2.89	2.49	1.79
Mammary Epithelial Cell, donor2	11350-117G9	4.63	2.03	2.03
Mammary Epithelial Cell, donor3	11422-118F9	8.73	3.24	0.50
Mast cell - stimulated, donor1	11487-119E2	6.78	4.75	8.14
Mast cell, donor1	11563-120D6	22.49	12.00	9.84
Mast cell, donor2	11565-120D8	14.86	27.64	6.54
Mast cell, donor3	11566-120D9	9.23	27.92	13.96
Mast cell, donor4	11567-120E1	9.75	22.87	15.07
Mast cell, expanded and stimulated, donor5	11940-126A5	10.53	15.08	12.09
Mast cell, expanded and stimulated, donor8	11942-126A7	49.03	14.59	16.34
Mast cell, expanded, donor5	11939-126A4	14.80	13.31	10.55
Mast cell, expanded, donor8	11941-126A6	141.76	31.63	20.92
Melanocyte - dark, donor1	11502-119F8	51.14	14.83	6.57
Melanocyte - dark, donor2	11582-120F7	4.15	7.61	0.00
Melanocyte - dark, donor3	11663-122F7	40.93	11.95	11.23
Melanocyte - light, donor1	11274-116H5	23.04	7.99	8.46
Melanocyte - light, donor2	11351-117H1	32.08	5.46	12.28
Melanocyte - light, donor3	11423-118G1	22.55	6.07	3.47
Melanocyte, donor1 (MC+1)	12641-134G4	49.04	18.01	5.00
Melanocyte, donor2 (MC+2)	12739-135I3	16.67	6.72	2.69
Melanocyte, donor3 (MC+3)	12837-137B2	32.14	11.25	9.91
Meningeal Cells, donor1	11493-119E8	9.68	12.03	4.34
Meningeal Cells, donor2	11573-120E7	10.56	17.61	4.84
Meningeal Cells, donor3	11654-122E7	11.33	9.21	1.87
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	5.13	6.84	2.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	7.95	5.33	3.52
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	1.31	11.83
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	2.62	10.47
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.74	4.31	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	3.39	4.02	4.24
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.53	6.53	6.53
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.71	5.93	5.71
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.84	5.84	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.57	9.00	1.84
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	5.68	9.83	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.35	4.09	3.35
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	5.26	10.13	1.18
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.75	3.86	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	9.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	10.25	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.03	8.51	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.19	11.88	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	8.71	9.43	1.45
Mesothelial Cells, donor1	11247-116E5	10.87	7.69	1.86
Mesothelial Cells, donor2	12156-128G5	9.51	4.50	2.00
Mesothelial Cells, donor3	11402-118D7	10.48	9.54	2.10
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1.35	2.70	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.36	4.19	4.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	11.48	3.24	8.54
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	4.34	4.34	4.34
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.88	2.70	7.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	6.95	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.01	5.26	6.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.38	1.86	10.24
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.93	6.71	3.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.73	2.77	10.30
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.08	4.42	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.74	2.66	8.74
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	3.95	7.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6.15	3.82	3.18
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	0.92	3.68
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.87	1.79	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	6.71	10.06
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.52	2.51	3.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.89	2.61	10.70
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	2.76	3.32
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.07	2.76	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.20	2.73	11.15
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.91	2.45	3.06
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.01	0.64	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.45	1.56	6.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.69	0.88	2.19
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.13	3.04	6.59
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.79	0.82	2.17
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.88	1.47	7.65
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	3.27	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.05	1.92	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.21	0.80	10.41
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	17.83	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	16.02	2.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	2.04	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.77	3.94	2.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	1.10	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	15.37	1.92	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.32	2.23	1.98
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	2.09	10.44
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	13.26	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.49	4.44	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.44	4.38	7.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	22.37	4.26	3.55
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	31.98	3.09	4.77
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.21	1.25	6.65
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.82	4.08	5.83
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	19.00	3.62	5.73
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	21.29	1.67	15.44
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	18.47	1.85	6.46
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	21.06	3.41	7.40
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	18.93	4.84	3.87
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.44	2.85	3.89
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.44	3.00	11.15
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	3.18	3.18
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.88	2.40	4.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.86	5.09	10.18
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.98	4.80	3.39
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	24.53	3.82	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	16.14	3.98	11.50
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.55	5.69	6.83
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	18.47	3.69	3.41
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	17.70	2.21	6.88
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.08	17.60	3.26
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.88	2.65	2.94
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	12.40	4.04	9.80
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.89	7.01	4.53
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.53	6.25	4.17
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	5.35	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.26	5.26	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	6.31	10.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.55	5.34	6.33
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1.86	7.45	8.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	2.63	3.76	2.25
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.06	4.79	7.72
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.41	5.54	3.17
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	5.89	5.16
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	5.50	3.30	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	9.33	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	1.07	2.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	19.32
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	3.03	5.05	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.64	2.95	5.06
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	117.13	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	13.99	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	83.07	1.51	10.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	1279.08	22.84	22.84
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	446.96	0.00	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	228.12	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	1305.10	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	7.54	5.82	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	11.50	24.56	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	8.01	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	3.34	6.26	4.17
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	10.65	33.66	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	14.36	14.36
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.04	5.44	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	11.03	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.44	5.02	7.53
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	5.58	10.23	4.18
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	3.78	8.65	5.40
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.25	14.30	9.25
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.47	7.94	11.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.95	13.26	6.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	3.63	5.89	3.85
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4.41	9.31	3.10
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.02	10.75	5.65
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.37	5.30	5.30
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	5.40	9.60	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.85	18.05	5.25
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.25	7.64	2.76
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	5.64	11.29	7.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	5.63	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	3.22	10.57	10.11
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	3.86	8.68	9.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	10.00	17.59	3.79
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	32.87	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	4.01	9.36	6.91
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	7.20	2.96
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.17	13.77	4.27
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.44	4.72	8.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	36.11	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	2.67	9.33	3.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	2.71	6.31	3.61
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.95	6.75	2.78
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3.71	9.29	9.29
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.68	16.65	5.68
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	3.91	3.91	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	1.74	10.46	3.92
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	2.71	11.31	2.71
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	2.65	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	4.65	7.31	11.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.95	12.40	11.41
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.45	4.98	2.68
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	5.14	13.91	4.84
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.40	8.84	3.32
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.10	4.74	2.71
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	25.55	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.05	8.54	9.15
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2.83	9.44	2.20
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	2.72	6.05	4.54
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	1.58	7.12	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	13.60	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	20.23	5.06
Myoblast, donor1	11241-116D8	7.95	2.86	1.24
Myoblast, donor2	11322-117D8	7.48	8.44	1.92
Myoblast, donor3	11398-118D3	7.40	4.04	2.86
NK T cell leukemia cell line:KHYG-1	10777-110G3	68.00	41.59	5.25
Natural Killer Cells, donor1	11230-116C6	29.83	18.14	21.53
Natural Killer Cells, donor2	11311-117C6	31.06	28.65	21.41
Natural Killer Cells, donor3	11387-118C1	52.09	27.98	21.17
Neural stem cells, donor1	11275-116H6	10.16	15.61	17.42
Neural stem cells, donor2	11352-117H2	1.93	7.70	17.33
Neurons, donor1	11494-119E9	19.34	40.96	15.93
Neurons, donor2	11574-120E8	15.63	27.96	17.83
Neurons, donor3	11655-122E8	23.02	27.95	25.49
Neutrophils, donor1	11233-116C9	87.23	49.18	10.21
Neutrophils, donor2	11314-117C9	147.84	43.48	0.00
Neutrophils, donor3	11390-118C4	210.13	63.53	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	4.99	10.45	2.26
Nucleus Pulposus Cell, donor2	11409-118E5	2.28	10.74	4.23
Nucleus Pulposus Cell, donor3	11462-119B4	5.01	13.04	1.00
Olfactory epithelial cells, donor1	11933-125I7	9.64	14.18	2.89
Olfactory epithelial cells, donor2	11934-125I8	6.51	13.90	4.34
Olfactory epithelial cells, donor3	11935-125I9	3.75	9.08	3.86
Olfactory epithelial cells, donor4	11936-126A1	4.09	12.95	2.14
Oligodendrocyte - precursors, donor1	11496-119F2	9.03	9.03	3.61
Osteoblast - differentiated, donor1	11276-116H7	9.36	8.08	2.34
Osteoblast - differentiated, donor2	11353-117H3	3.43	5.72	2.29
Osteoblast - differentiated, donor3	11425-118G3	2.48	9.31	5.59
Osteoblast, donor1	11277-116H8	8.01	7.82	5.86
Osteoblast, donor2	11354-117H4	12.64	9.13	1.40
Osteoblast, donor3	11426-118G4	15.82	20.97	1.42
Pancreatic stromal cells, donor1	11249-116E7	4.21	4.55	2.95
Pericytes, donor1	11491-119E6	7.45	10.35	2.67
Pericytes, donor2	11571-120E5	8.15	15.62	7.24
Pericytes, donor3	11652-122E5	9.36	17.50	1.83
Perineurial Cells, donor1	11499-119F5	5.20	11.87	1.36
Perineurial Cells, donor2	11579-120F4	4.42	6.16	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	14.66	8.92	14.66
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	16.41	16.90	15.18
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	17.99	16.05	14.88
Placental Epithelial Cells, donor1	11278-116H9	24.39	6.94	1.43
Placental Epithelial Cells, donor2	11355-117H5	0.00	8.87	1.11
Placental Epithelial Cells, donor3	11427-118G5	6.87	14.33	5.50
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.59	4.11	0.95
Preadipocyte - breast, donor1	11467-119B9	4.69	2.44	3.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	6.00	6.13	2.87
Preadipocyte - breast, donor2	11328-117E5	3.83	5.63	2.03
Preadipocyte - omental, donor1	11468-119C1	5.11	3.94	1.81
Preadipocyte - omental, donor2	11329-117E6	8.73	7.42	2.62
Preadipocyte - omental, donor3	11403-118D8	7.74	7.02	4.73
Preadipocyte - perirenal, donor1	11469-119C2	13.78	10.83	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	9.83	3.69	6.76
Preadipocyte - subcutaneous, donor2	11356-117H6	4.07	3.90	4.60
Preadipocyte - subcutaneous, donor3	11428-118G6	4.77	6.81	1.19
Preadipocyte - visceral, donor1	11280-116I2	1.96	2.33	3.54
Preadipocyte - visceral, donor2	11357-117H7	1.38	4.14	1.38
Preadipocyte - visceral, donor3	11429-118G7	2.72	4.91	2.82
Prostate Epithelial Cells (polarized), donor1	11253-116F2	20.97	6.18	7.39
Prostate Epithelial Cells, donor2	11331-117E8	9.75	7.31	0.54
Prostate Epithelial Cells, donor3	11404-118D9	3.61	7.65	2.33
Prostate Stromal Cells, donor1	11254-116F3	8.31	4.21	2.96
Prostate Stromal Cells, donor2	11332-117E9	5.02	4.12	1.26
Prostate Stromal Cells, donor3	11405-118E1	4.69	5.53	5.84
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.93	8.39	6.57
Renal Cortical Epithelial Cells, donor2	11596-120H3	6.65	10.95	1.94
Renal Epithelial Cells, donor1	11517-119H5	3.04	2.54	6.59
Renal Epithelial Cells, donor2	11597-120H4	9.25	6.40	8.54
Renal Epithelial Cells, donor3	11678-122H4	7.41	11.54	1.27
Renal Glomerular Endothelial Cells, donor1	11514-119H2	36.77	23.83	4.09
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.82	13.61	6.20
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.77	13.32	8.21
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	5.32	5.32
Renal Mesangial Cells, donor1	11518-119H6	5.72	9.02	8.14
Renal Mesangial Cells, donor2	11598-120H5	4.39	14.42	3.13
Renal Mesangial Cells, donor3	11679-122H5	4.44	13.04	8.04
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	4.03	5.64	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.53	4.64	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	5.40	9.06	4.05
Retinal Pigment Epithelial Cells, donor0	11215-116A9	13.22	14.78	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.36	11.09	6.54
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	16.47	5.15
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.29	9.03	3.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	6.41	7.62	6.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	51.82	33.06	8.93
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	55.04	22.01	8.81
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	56.27	39.44	11.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	44.99	21.45	10.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	43.60	29.89	11.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	52.31	21.30	13.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	60.16	44.90	9.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.34	32.63	10.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	59.40	38.37	12.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	43.13	28.34	12.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	42.05	29.80	8.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	46.59	24.37	12.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	49.64	33.28	11.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	41.10	30.16	9.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	57.97	38.94	12.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	42.44	26.38	16.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	41.27	30.37	11.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	46.79	24.43	12.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	43.13	37.29	10.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	40.88	28.42	12.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	50.22	34.18	18.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	42.61	25.95	11.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	36.72	29.99	8.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	37.60	29.05	17.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	38.11	28.44	14.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	37.53	28.33	13.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	55.34	35.86	20.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	51.89	20.05	25.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	42.86	25.79	14.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	47.94	31.57	21.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	38.98	23.22	20.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	45.57	29.20	13.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	36.35	32.38	22.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	30.28	21.67	20.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	36.27	28.44	18.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	30.27	22.56	28.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.62	14.61	24.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	22.36	17.97	23.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	27.25	18.39	26.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	27.10	22.16	16.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	26.19	24.71	26.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	29.32	31.72	20.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	33.60	27.93	17.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	41.67	40.95	13.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	53.41	48.97	20.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	50.38	34.75	14.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	32.14	23.76	22.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.31	18.74	26.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	54.83	32.31	12.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	49.05	30.42	33.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	46.24	39.55	18.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	62.09	26.82	12.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	36.19	22.85	13.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	50.62	41.64	13.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	37.08	19.84	17.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	44.40	28.17	15.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	42.67	45.07	13.82
Schwann Cells, donor1	11498-119F4	6.39	15.80	4.51
Schwann Cells, donor2	11578-120F3	13.61	10.21	0.00
Schwann Cells, donor3	11659-122F3	7.01	9.20	2.63
Sebocyte, donor1	11220-116B5	4.38	8.22	1.10
Sebocyte, donor2	11301-117B5	1.38	5.51	0.46
Sebocyte, donor3	11378-118B1	1.65	3.30	1.24
Sertoli Cells, donor1	11255-116F4	13.25	4.97	0.00
Sertoli Cells, donor2	11333-117F1	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	5.98	6.60	6.51
Skeletal Muscle Cells, donor2	11358-117H8	6.51	7.23	10.12
Skeletal Muscle Cells, donor3	11430-118G8	29.26	28.43	1.67
Skeletal Muscle Cells, donor4	11451-119A2	8.33	8.48	0.94
Skeletal Muscle Cells, donor5	11455-119A6	4.76	9.22	0.89
Skeletal Muscle Cells, donor6	11459-119B1	6.77	10.00	3.69
Skeletal Muscle Satellite Cells, donor1	11240-116D7	3.91	10.96	2.65
Skeletal Muscle Satellite Cells, donor2	11321-117D7	3.57	11.27	2.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	6.45	10.71	3.37
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	9.94	9.18	6.57
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	8.69	11.58	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.39	17.34	8.81
Skin - palm, donor1	10286-104F7	21.49	40.29	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.62	3.46	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	24.54	11.45	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.06	4.41	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	8.62	4.45	1.67
Small Airway Epithelial Cells, donor2	11334-117F2	5.63	5.63	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	20.09	12.05	5.92
Small Airway Epithelial Cells, donor3	11406-118E2	8.39	7.50	2.47
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.57	8.64	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.45	6.89	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.82	5.29	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.51	5.75	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.06	5.12	3.94
Smooth Muscle Cells - Aortic, donor3	11432-118H1	8.50	7.73	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	9.01	9.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	9.45	5.19	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	6.21	7.31	3.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	17.03	25.35	2.43
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	4.56	6.19	6.51
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	3.54	4.43	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	2.56	6.55	2.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.95	2.28	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	1.52	7.92	3.35
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.85	7.07	2.27
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	13.83	12.40	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	1.62	2.06	2.65
Smooth Muscle Cells - Colonic, donor2	11320-117D6	4.30	4.74	2.37
Smooth Muscle Cells - Colonic, donor3	11396-118D1	3.78	5.46	3.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.66	7.12	4.33
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	11.86	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.07	12.25	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.78	3.41	2.73
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	4.48	10.05	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	19.63	8.45	3.32
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	10.47	8.87	2.73
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	14.49	13.89	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	5.30	7.68	3.97
Smooth Muscle Cells - Prostate, donor1	11257-116F6	5.46	6.79	2.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	5.13	4.88	3.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.57	5.07	5.07
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	9.35	5.43	2.56
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	4.50	7.50	6.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	21.97	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	16.74	14.88	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.19	9.59	4.04
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.03	7.83	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.65	1.77	2.36
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	4.42	6.16	2.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	2.80	7.47	4.20
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	18.71	9.07	2.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	15.30	15.30	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.55	21.62	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	4.33	5.03	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	3.02	7.96	0.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.48	3.33	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	17.37	9.30	2.94
Smooth Muscle Cells - Uterine, donor1	11258-116F7	3.09	1.77	2.43
Smooth Muscle Cells - Uterine, donor3	11466-119B8	3.80	6.44	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.28	9.13	3.69
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.29	3.70	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	3.72	4.84	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	3.95	4.67	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	5.68	3.97	2.56
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	9.06	5.12	5.51
Smooth muscle cells - airway, control, donor1	11966-126D4	2.29	6.09	2.29
Smooth muscle cells - airway, control, donor2	11967-126D5	3.19	11.18	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	3.76	3.34	4.18
Smooth muscle cells - airway, control, donor4	11969-126D7	5.04	7.33	3.21
Synoviocyte, donor1	11291-117A4	7.41	5.72	1.68
Synoviocyte, donor2	11368-117I9	5.36	6.54	3.35
Synoviocyte, donor3	11440-118H9	7.82	9.16	4.69
Trabecular Meshwork Cells, donor1	11532-120A2	9.65	10.36	6.07
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	7.93	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	4.40	9.96	4.63
Tracheal Epithelial Cells, donor1	11292-117A5	6.38	5.09	2.87
Tracheal Epithelial Cells, donor2	11369-118A1	7.34	7.34	4.25
Tracheal Epithelial Cells, donor3	11441-118I1	9.16	6.30	6.30
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	6.27	7.26	6.03
Urethra, donor2	10319-105A4	8.99	30.57	19.78
Urothelial Cells, donor1	11520-119H8	5.05	6.11	1.33
Urothelial Cells, donor2	11600-120H7	4.01	8.81	0.80
Urothelial Cells, donor3	11681-122H7	5.04	8.25	0.46
Urothelial cells, donor0	11216-116B1	2.01	6.02	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	106.77	14.24	6.23
Whole blood (ribopure), donor090309, donation2	12180-129A2	148.68	32.88	8.58
Whole blood (ribopure), donor090309, donation3	12181-129A3	74.61	18.48	8.21
Whole blood (ribopure), donor090325, donation1	12176-128I7	49.24	17.91	6.54
Whole blood (ribopure), donor090325, donation2	12177-128I8	55.20	15.69	6.97
Whole blood (ribopure), donor090612, donation1	12182-129A4	102.04	15.62	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	125.74	20.19	9.18
Whole blood (ribopure), donor090612, donation3	12184-129A6	75.77	27.39	4.56
Wilms' tumor cell line:G-401	10809-111A8	9.13	9.25	5.06
Wilms' tumor cell line:HFWT	10597-108E3	14.08	18.48	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	11.73	12.29	6.98
achilles tendon, donor2	10292-104G4	20.67	24.80	18.60
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	4.59	5.10	4.59
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	37.84	34.13	11.38
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	36.80	53.18	7.72
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	20.68	23.67	18.23
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	46.38	17.71	8.15
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	66.62	30.24	20.30
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	88.74	25.32	9.26
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	61.69	44.06	5.29
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	40.02	32.67	10.21
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	64.85	68.73	16.70
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	10.12	10.30	19.87
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	35.10	27.30
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	35.09	18.13	16.50
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	28.22	20.19	33.66
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	19.58	16.07	30.69
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	10.22	9.30	5.58
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	34.96	19.74	7.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.68	9.82	3.07
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	6.83	9.39	3.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	9.40	7.58	7.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	10.83	7.94	6.50
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	15.37	7.57	7.35
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	23.68	8.01	4.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	163.52	52.03	20.44
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	84.75	28.25	10.55
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	33.15	43.61	10.47
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	129.34	20.62	22.49
adenocarcinoma cell line:IM95m	10796-110I4	13.42	18.84	6.12
adipose tissue, adult, pool1	10010-101C1	9.00	6.05	6.52
adipose, donor1	10184-103D4	25.22	82.10	15.25
adipose, donor2	10185-103D5	12.98	34.06	13.38
adipose, donor3	10186-103D6	26.14	38.94	11.16
adipose, donor4	10187-103D7	32.07	32.07	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	9.15	28.88	8.68
adrenal gland, adult, pool1	10081-102A9	14.55	7.28	14.55
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.76	29.22	8.14
alveolar cell carcinoma cell line:SW 1573	10708-109H6	21.08	27.15	12.15
amniotic membrane cells, donor1	12235-129G3	6.26	16.69	3.94
amniotic membrane cells, donor2	12236-129G4	5.07	8.79	7.78
amniotic membrane cells, donor3	12237-129G5	8.84	24.75	4.12
amygdala - adult, donor10196	10167-103B5	15.42	14.23	14.23
amygdala, adult, donor10252	10151-102I7	17.44	35.69	22.91
amygdala, newborn, donor10223	10360-105E9	24.53	10.33	9.36
anaplastic carcinoma cell line:8305C	10428-106D5	9.55	15.15	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	46.99	9.27	2.43
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	37.08	38.08	11.02
aorta, adult, pool1	10052-101G7	7.45	18.83	7.85
appendix, adult	10189-103D9	14.36	19.02	10.09
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	62.60	26.14	14.45
artery, adult	10190-103E1	6.79	10.87	16.30
astrocytoma cell line:TM-31	10425-106D2	7.10	8.11	2.17
b cell line:RPMI1788	10427-106D4	12.79	20.82	2.97
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.71	10.82	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	10.02	6.85	1.39
bile duct carcinoma cell line:TFK-1	10496-107C1	1.67	1.84	1.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.93	12.30	16.78
bladder, adult, pool1	10011-101C2	3.91	10.76	3.26
blood, adult, pool1	10053-101G8	37.65	22.15	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	0.86	5.14	3.43
bone marrow, adult	10192-103E3	8.77	13.50	4.72
brain, adult, donor1	10084-102B3	19.48	19.48	18.45
brain, adult, pool1	10012-101C3	7.46	10.91	8.35
brain, fetal, pool1	10085-102B4	5.34	37.40	24.04
breast carcinoma cell line:MCF7	10482-107A5	10.90	12.55	6.28
breast carcinoma cell line:MDA-MB-453	10419-106C5	23.22	16.98	9.24
breast, adult, donor1	10080-102A8	11.36	16.42	8.21
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	18.55	16.39	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.36	22.26	4.95
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.06	18.88	2.07
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	6.78	6.78	4.12
carcinoid cell line:NCI-H1770	10703-109H1	30.56	38.55	7.05
carcinoid cell line:NCI-H727	10735-110B6	15.86	8.42	4.48
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	28.20	5.39
carcinosarcoma cell line:JHUCS-1	10642-109A3	29.55	35.93	9.05
caudate nucleus - adult, donor10196	10177-103C6	11.51	20.72	14.97
caudate nucleus, adult, donor10252	10164-103B2	13.39	29.28	25.43
caudate nucleus, adult, donor10258	10379-105H1	15.28	16.05	14.52
caudate nucleus, newborn, donor10223	10354-105E3	21.24	11.35	10.25
cerebellum - adult, donor10196	10173-103C2	2.91	46.61	11.65
cerebellum, adult, donor10252	10166-103B4	16.23	54.45	45.69
cerebellum, adult, pool1	10083-102B2	8.97	35.53	15.18
cerebellum, newborn, donor10223	10357-105E6	49.82	47.33	19.10
cerebral meninges, adult	10188-103D8	9.83	17.65	11.09
cerebrospinal fluid, donor2	10294-104G6	16.81	19.00	19.00
cervical cancer cell line:D98-AH2	10552-107I3	7.62	7.91	11.22
cervical cancer cell line:ME-180	10553-107I4	16.24	5.63	5.30
cervix, adult, pool1	10013-101C4	6.51	11.44	9.03
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.98	11.98	2.93
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	15.68	6.53
choriocarcinoma cell line:BeWo	10423-106C9	18.14	15.04	4.10
choriocarcinoma cell line:SCH	10785-110H2	17.25	6.78	4.68
choriocarcinoma cell line:T3M-3	10618-108G6	4.74	9.01	3.79
chorionic membrane cells, donor1	12238-129G6	6.27	11.68	2.56
chorionic membrane cells, donor2	12239-129G7	6.36	6.76	5.37
chorionic membrane cells, donor3	12240-129G8	6.04	14.29	3.85
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	45.44	22.22	8.08
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	37.46	24.01	4.03
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	73.70	24.92	6.34
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	163.84	26.71	4.88
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	214.30	29.99	5.56
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	147.62	20.77	4.07
chronic myelogenous leukemia cell line:K562	10454-106G4	176.08	21.79	11.19
chronic myelogenous leukemia cell line:KU812	10409-106B4	129.79	38.31	9.64
clear cell carcinoma cell line:JHOC-5	10638-108I8	3.43	22.17	1.37
clear cell carcinoma cell line:TEN	10636-108I6	19.61	10.06	1.91
colon carcinoma cell line:CACO-2	10513-107D9	29.10	6.41	15.38
colon carcinoma cell line:COLO-320	10420-106C6	10.26	19.76	13.30
colon, adult, donor1	10082-102B1	15.47	21.42	8.33
colon, adult, pool1	10014-101C5	8.11	8.81	10.69
colon, fetal, donor1	10070-101I7	17.92	30.28	1.24
common myeloid progenitor CMP, donor1	12130-128D6	73.34	45.84	45.84
common myeloid progenitor CMP, donor2	12134-128E1	50.07	100.15	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	43.34	5.10	29.32
cord blood derived cell line:COBL-a 24h infection	10453-106G3	36.07	7.70	9.51
cord blood derived cell line:COBL-a untreated	10449-106F8	42.30	7.33	9.02
corpus callosum, adult, pool1	10042-101F6	14.04	10.39	15.59
cruciate ligament, donor2	10295-104G7	16.21	27.56	11.35
diaphragm, fetal, donor1	10069-101I6	8.03	23.27	9.63
diencephalon, adult	10193-103E4	8.40	12.96	5.76
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	24.34	28.01	4.13
ductal cell carcinoma cell line:KLM-1	10438-106E6	7.69	5.90	2.82
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	12.52	4.57	3.13
ductus deferens, adult	10196-103E7	10.47	11.46	11.46
duodenum, fetal, donor1, tech_rep1	10071-101I8	8.64	36.01	7.20
duodenum, fetal, donor1, tech_rep2	10071-101I8	13.98	19.13	4.41
dura mater, adult, donor1	10041-101F5	12.31	8.18	8.01
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	45.75	4.66	42.86
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	28.80	9.03	8.88
embryonic pancreas cell line:1B2C6	10604-108F1	4.93	11.72	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	3.63	14.53	3.63
embryonic pancreas cell line:1C3IKEI	10606-108F3	4.01	9.88	3.40
embryonic pancreas cell line:2C6	10603-108E9	5.25	18.39	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	3.35	3.35	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	4.71	16.85	10.51
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	34.41	16.72	0.96
epidermoid carcinoma cell line:A431	10426-106D3	13.01	8.11	2.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	20.02	15.29	3.41
epididymis, adult	10197-103E8	12.77	15.07	4.81
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	3.02	5.32	2.48
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.93	1.97	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	25.55	14.55	9.83
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	17.03	10.73	13.29
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	24.98	9.97	10.87
esophagus, adult, pool1	10015-101C6	6.26	7.22	4.57
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	5.89	5.51	4.88
eye - muscle inferior rectus, donor1	10272-104E2	28.97	43.46	12.07
eye - muscle lateral, donor2	10298-104H1	12.63	25.25	23.15
eye - muscle medial, donor2	10299-104H2	11.91	28.28	13.39
eye - muscle superior, donor2	10297-104G9	19.49	22.93	20.64
eye - vitreous humor, donor1	10268-104D7	27.69	45.18	4.37
eye, fetal, donor1	10054-101G9	21.61	26.69	3.81
fibrosarcoma cell line:HT-1080	10758-110E2	7.95	8.59	2.82
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	17.09	23.74	3.32
frontal lobe, adult, pool1	10040-101F4	10.23	16.70	15.48
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.51	17.41	3.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	5.30	17.65	1.55
gall bladder, adult	10198-103E9	7.48	12.55	3.62
gamma delta positive T cells, donor1	11937-126A2	4.83	16.11	26.84
gamma delta positive T cells, donor2	11938-126A3	15.31	18.67	17.55
gastric adenocarcinoma cell line:MKN1	10614-108G2	6.76	6.13	4.01
gastric adenocarcinoma cell line:MKN45	10612-108F9	11.22	18.76	2.51
gastric cancer cell line:AZ521	10549-107H9	12.62	16.40	23.45
gastric cancer cell line:GSS	10560-108A2	10.98	32.03	4.58
gastrointestinal carcinoma cell line:ECC12	10615-108G3	62.60	15.54	2.06
giant cell carcinoma cell line:LU65	10487-107B1	5.39	2.52	2.41
giant cell carcinoma cell line:Lu99B	10433-106E1	6.58	13.72	1.96
glassy cell carcinoma cell line:HOKUG	10688-109F4	4.99	4.74	2.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	13.83	7.60	6.76
glioblastoma cell line:A172, tech_rep2	10444-106F3	10.67	9.27	4.35
glioblastoma cell line:T98G	10485-107A8	10.26	11.15	3.09
glioma cell line:GI-1	10413-106B8	10.54	11.13	1.76
globus pallidus - adult, donor10196	10175-103C4	21.87	26.97	10.93
globus pallidus, adult, donor10252	10161-103A8	26.36	25.63	17.57
globus pallidus, adult, donor10258	10367-105F7	13.69	16.43	12.32
globus pallidus, newborn, donor10223	10364-105F4	20.25	7.46	13.86
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	39.15	48.94
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	15.68	10.45
granulosa cell tumor cell line:KGN	10624-108H3	8.00	14.72	3.84
hIPS +CCl2, biol_rep1	14383-156B9	11.02	14.23	4.13
hIPS +CCl2, biol_rep2	14384-156C1	12.35	9.60	4.57
hIPS +CCl2, biol_rep3	14385-156C2	12.88	8.37	4.51
hIPS, biol_rep1	14380-156B6	4.31	4.31	5.75
hIPS, biol_rep2	14381-156B7	8.92	8.23	0.69
hIPS, biol_rep3	14382-156B8	9.93	14.35	8.83
hairy cell leukemia cell line:Mo	10712-109I1	19.54	19.54	4.02
heart - mitral valve, adult	10205-103F7	8.67	14.95	7.18
heart - pulmonic valve, adult	10206-103F8	6.80	13.60	8.63
heart - tricuspid valve, adult	10207-103F9	24.98	10.82	11.66
heart, adult, diseased post-infarction, donor1	10050-101G5	10.00	20.41	12.24
heart, adult, diseased, donor1	10051-101G6	13.20	34.92	14.05
heart, adult, pool1	10016-101C7	7.82	9.20	11.73
heart, fetal, pool1	10046-101G1	17.46	19.82	11.29
hepatic mesenchymal tumor cell line:LI90	10778-110G4	3.70	19.75	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	20.22	15.46	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	43.31	13.81	4.86
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	42.00	13.35	5.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	41.13	14.75	6.27
hepatoma cell line:Li-7	10484-107A7	17.35	7.45	2.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.55	12.56	5.13
hippocampus - adult, donor10196	10169-103B7	8.52	23.66	10.41
hippocampus, adult, donor10252	10153-102I9	15.72	31.02	17.96
hippocampus, adult, donor10258	10374-105G5	7.97	7.97	20.42
hippocampus, newborn, donor10223	10363-105F3	19.39	9.87	8.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	57.98	33.57	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.10	22.97	4.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	40.37	19.04	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	14.10	36.09	14.66
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	14.46	38.22	13.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	12.53	30.37	10.25
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	42.33	33.57	13.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	28.87	38.13	9.26
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	29.61	18.35	9.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.18	18.23	9.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	24.59	27.64	9.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	18.18	17.51	6.06
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	29.11	16.27	2.66
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	24.07	23.58	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	53.24	21.82	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	9.55	30.55	20.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	12.65	22.24	25.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	20.99	48.98	18.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	13.94	35.42	9.42
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	14.10	36.38	10.46
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.60	33.20	11.59
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.37	35.93	12.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	16.26	33.39	10.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.64	31.39	11.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	35.29	24.57	4.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	30.81	22.82	5.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	65.33	24.91	6.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	17.60	27.46	16.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	15.20	27.87	17.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.64	26.93	15.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.72	33.10	12.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	25.90	25.90	22.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	17.96	25.65	12.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.62	19.94	13.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	15.90	31.80	20.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.48	20.16	14.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	29.95	23.18	6.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	33.42	23.17	7.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	32.68	25.37	7.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	12.53	30.26	21.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	130.13	16.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	21.18	42.03	14.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	25.72	30.10	14.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	17.37	29.67	10.86
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	32.03	27.05	12.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	23.87	15.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	20.58	28.57	11.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.66	23.44	14.01
immature langerhans cells, donor1	11904-125F5	51.34	13.32	9.44
immature langerhans cells, donor2	11905-125F6	72.88	25.35	7.92
insula, adult, pool1	10039-101F3	11.73	16.56	20.25
keratoacanthoma cell line:HKA-1	10791-110H8	8.13	9.10	3.58
kidney, adult, pool1	10017-101C8	8.51	6.11	11.01
kidney, fetal, pool1	10045-101F9	10.61	14.57	6.44
large cell lung carcinoma cell line:IA-LM	10509-107D5	16.33	14.91	4.83
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.44	10.78	2.90
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	7.71	6.97	3.12
left atrium, adult, donor1	10079-102A7	12.53	30.51	7.08
left ventricle, adult, donor1	10078-102A6	8.09	24.27	4.55
leiomyoblastoma cell line:G-402	10721-110A1	5.20	9.30	3.56
leiomyoma cell line:10964C	10569-108B2	3.23	3.59	4.31
leiomyoma cell line:15242A	10570-108B3	7.61	4.35	1.63
leiomyoma cell line:15425	10571-108B4	2.43	3.16	4.37
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	23.00	13.59
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	79.22	30.58	7.44
liposarcoma cell line:KMLS-1	10782-110G8	4.53	9.69	1.25
liposarcoma cell line:SW 872	10726-110A6	17.42	17.67	9.50
liver, adult, pool1	10018-101C9	28.52	5.51	10.86
liver, fetal, pool1	10086-102B5	72.43	12.23	8.47
locus coeruleus - adult, donor10196	10182-103D2	12.69	15.17	11.96
locus coeruleus, adult, donor10252	10165-103B3	21.41	19.93	16.43
locus coeruleus, adult, donor10258	10375-105G6	10.44	13.82	14.95
locus coeruleus, newborn, donor10223	10362-105F2	15.14	8.83	6.73
lung adenocarcinoma cell line:A549	10499-107C4	4.29	3.60	2.77
lung adenocarcinoma cell line:PC-14	10408-106B3	6.20	6.89	3.45
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	16.74	32.16	6.85
lung, adult, pool1	10019-101D1	6.50	9.45	5.08
lung, fetal, donor1	10068-101I5	50.23	17.70	8.85
lung, right lower lobe, adult, donor1	10075-102A3	8.25	13.75	11.00
lymph node, adult, donor1	10077-102A5	14.67	10.89	7.10
lymphangiectasia cell line:DS-1	10727-110A7	69.92	11.18	3.51
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.19	8.00	6.34
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	5.95	2.55	4.25
mature adipocyte, donor1	12231-129F8	16.43	7.10	23.98
mature adipocyte, donor2	12232-129F9	15.15	8.09	14.32
mature adipocyte, donor3	12233-129G1	14.46	7.82	15.65
mature adipocyte, donor4	12234-129G2	9.48	13.16	15.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	13.10	17.39	4.77
medial frontal gyrus - adult, donor10196	10170-103B8	14.66	28.20	15.79
medial frontal gyrus, adult, donor10252	10150-102I6	22.25	32.18	18.57
medial frontal gyrus, adult, donor10258	10368-105F8	12.07	26.37	16.20
medial frontal gyrus, newborn, donor10223	10352-105E1	22.60	20.47	12.79
medial temporal gyrus - adult, donor10196	10183-103D3	14.34	28.35	12.99
medial temporal gyrus, adult, donor10252	10156-103A3	24.19	37.14	23.56
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	7.71	9.63
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	32.30	12.56	12.20
medulla oblongata - adult, donor10196	10174-103C3	12.33	15.58	11.03
medulla oblongata, adult, donor10252	10155-103A2	18.27	22.60	17.34
medulla oblongata, adult, pool1	10038-101F2	10.37	8.57	12.90
medulla oblongata, newborn, donor10223	10361-105F1	20.14	6.25	9.03
medulloblastoma cell line:D283 Med	10838-111E1	12.84	28.12	5.98
medulloblastoma cell line:ONS-76	10759-110E3	15.53	20.91	2.08
melanoma cell line:COLO 679	10514-107E1	14.23	8.62	10.92
melanoma cell line:G-361	10465-106H6	12.22	19.82	4.61
meningioma cell line:HKBMM	10691-109F7	3.80	8.68	3.26
merkel cell carcinoma cell line:MKL-1	10843-111E6	78.42	69.61	16.74
merkel cell carcinoma cell line:MS-1	10844-111E7	96.17	62.73	22.55
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.20	13.96	1.84
mesenchymal precursor cell - adipose, donor2	11748-123G2	3.64	4.73	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.94	3.73	2.90
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.87	8.43	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	7.51	7.51	2.31
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.94	7.63	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	2.75	5.15	1.72
mesenchymal precursor cell - cardiac, donor2	11753-123G7	4.60	6.90	4.03
mesenchymal precursor cell - cardiac, donor3	11754-123G8	5.44	8.89	1.72
mesenchymal precursor cell - cardiac, donor4	11755-123G9	5.94	7.97	3.65
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	14.51	10.95	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	3.62	9.55	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	11.48	16.05	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.38	8.73	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.15	12.05	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	6.47	10.06	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.97	13.14	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	11.63	5.70	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	12.17	10.07	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	9.56	13.90	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	19.69	17.33	2.01
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	7.36	10.68	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.30	9.44	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	27.79	19.79	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	5.48	8.22	4.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.65	6.65	3.07
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.07	7.59	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.01	5.55	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.83	6.83	2.59
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	4.06	4.40	5.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.25	4.32	3.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	4.63	2.32	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	5.48	4.90	4.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	5.80	5.35	5.13
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	5.05	8.17	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	3.67	7.33	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.03	6.71	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	5.32	8.19	3.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.87	5.58	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	2.73	8.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	10.33	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	7.47	7.79	4.22
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	0.00	11.64	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	3.20	4.26	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	3.27	6.54	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	3.50	6.61	4.66
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	6.30	8.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	8.94	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	1.78	8.30	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	2.44	2.44	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.97	6.97	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	5.52	6.90	3.79
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.56	2.44	4.07
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.97	11.92	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	8.25	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.68	9.04	6.86
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	5.35	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	4.73	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	10.27
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	7.57	4.13	6.20
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.95	4.45	9.90
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	11.22	12.34
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.09	2.54	12.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.64	4.84	8.87
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	4.36	19.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	7.60	10.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.89	5.46	8.50
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	4.52	18.08
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	3.29	4.94	14.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.96	4.76	6.55
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.22	4.22	7.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	8.15	3.06	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.87	9.28	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	2.13	6.14	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	6.95	6.26	3.48
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	17.09	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	10.48	11.71	2.98
mesothelioma cell line:Mero-25	10850-111F4	4.77	4.54	9.31
mesothelioma cell line:Mero-41	10851-111F5	6.60	8.56	4.16
mesothelioma cell line:Mero-48a	10852-111F6	12.84	15.72	5.31
mesothelioma cell line:Mero-82	10853-111F7	6.83	3.68	2.89
mesothelioma cell line:Mero-83	10854-111F8	10.04	7.66	5.28
mesothelioma cell line:Mero-84	10855-111F9	4.80	4.30	3.03
mesothelioma cell line:Mero-95	10856-111G1	6.21	5.59	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	10.27	8.94	4.14
mesothelioma cell line:NCI-H226	10846-111E9	4.34	5.07	1.99
mesothelioma cell line:NCI-H2452	10848-111F2	7.35	7.35	2.90
mesothelioma cell line:NCI-H28	10845-111E8	18.83	22.14	2.54
mesothelioma cell line:No36	10857-111G2	7.50	5.55	6.85
mesothelioma cell line:ONE58	10858-111G3	18.70	9.48	4.88
migratory langerhans cells, donor1	11901-125F2	11.90	20.73	3.65
migratory langerhans cells, donor2	11902-125F3	10.87	13.80	5.01
migratory langerhans cells, donor3	11903-125F4	9.51	13.10	8.44
mixed mullerian tumor cell line:HTMMT	10689-109F5	8.16	16.98	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.30	32.43	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	14.28	9.91	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	23.03	22.45	3.23
myelodysplastic syndrome cell line:SKM-1	10772-110F7	15.15	12.20	7.58
myeloma cell line:PCM6	10474-106I6	13.64	11.86	6.33
myxofibrosarcoma cell line:MFH-ino	10600-108E6	3.04	9.64	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.03	20.59	9.02
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.90	7.58	5.57
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.47	6.47	5.59
nasal epithelial cells, donor2	12227-129F4	3.31	3.31	0.55
neuroblastoma cell line:CHP-134	10508-107D4	23.70	36.81	46.93
neuroblastoma cell line:NB-1	10539-107G8	28.06	22.08	11.60
neuroblastoma cell line:NBsusSR	10607-108F4	11.18	13.29	4.64
neuroblastoma cell line:NH-12	10555-107I6	11.18	34.10	7.45
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	9.49	21.82	4.98
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	11.72	18.53	7.13
neuroectodermal tumor cell line:TASK1	10774-110F9	8.05	18.92	5.43
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.81	19.07	15.26
neurofibroma cell line:Hs 53.T	10729-110A9	5.06	14.11	0.00
neutrophil PMN, donor1	12133-128D9	29.75	0.00	14.87
neutrophil PMN, donor2	12137-128E4	13.28	0.00	26.56
neutrophil PMN, donor3	12141-128E8	47.35	28.41	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	92.68	173.01	21.99
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	40.83	22.41	11.21
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	7.37	14.75	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	9.99	11.82	5.78
nucleus accumbens, adult, pool1	10037-101F1	11.72	17.06	15.94
occipital cortex - adult, donor10196	10172-103C1	16.48	28.85	20.60
occipital cortex, adult, donor10252	10163-103B1	30.59	43.21	21.47
occipital cortex, newborn, donor10223	10355-105E4	32.39	16.74	11.28
occipital lobe, adult, donor1	10076-102A4	15.74	27.03	14.69
occipital lobe, fetal, donor1	10073-102A1	30.04	135.60	18.88
occipital pole, adult, pool1	10036-101E9	9.86	13.64	17.35
olfactory region, adult	10195-103E6	10.32	22.54	9.74
optic nerve, donor1	10277-104E7	38.02	32.02	22.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	16.06	8.09	12.07
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	4.95	4.53	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	5.93	7.79	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.05	8.09	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	9.11	16.76	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	11.21	12.15	4.67
osteosarcoma cell line:HS-Os-1	10558-107I9	13.36	4.67	1.48
ovary, adult, pool1	10020-101D2	6.20	5.50	5.15
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	15.03	14.12	1.83
pancreas, adult, donor1	10049-101G4	11.29	16.93	6.58
pancreatic carcinoma cell line:NOR-P1	10698-109G5	19.01	10.34	7.55
papillary adenocarcinoma cell line:8505C	10437-106E5	16.69	11.92	4.60
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	19.37	9.27	2.81
paracentral gyrus, adult, pool1	10035-101E8	15.28	14.55	15.01
parietal cortex, adult, donor10258	10373-105G4	10.28	13.21	17.62
parietal lobe - adult, donor10196	10171-103B9	10.35	23.51	8.46
parietal lobe, adult, donor10252	10157-103A4	31.64	41.62	19.38
parietal lobe, adult, pool1	10034-101E7	11.63	16.65	20.44
parietal lobe, fetal, donor1	10072-101I9	39.76	133.84	19.40
parietal lobe, newborn, donor10223	10356-105E5	30.66	14.95	10.47
parotid gland, adult	10199-103F1	9.87	11.10	3.70
penis, adult	10200-103F2	6.98	17.19	11.28
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.51	17.85	6.88
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	10.34	20.54	4.66
pineal gland - adult, donor10196	10179-103C8	3.87	12.26	8.39
pineal gland, adult, donor10252	10160-103A7	4.15	18.95	20.73
pineal gland, adult, donor10258	10377-105G8	3.76	6.90	20.07
pituitary gland - adult, donor10196	10180-103C9	5.06	20.24	18.21
pituitary gland, adult, donor10252	10162-103A9	10.94	25.02	23.45
pituitary gland, adult, donor10258	10378-105G9	3.40	9.36	21.28
placenta, adult, pool1	10021-101D3	4.41	4.62	4.84
plasma cell leukemia cell line:ARH-77	10840-111E3	12.85	20.39	10.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	7.63	6.85	0.78
pons, adult, pool1	10033-101E6	8.35	9.04	14.29
postcentral gyrus, adult, pool1	10032-101E5	11.94	17.35	18.13
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	10.46	31.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	11.02	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	8.89	12.38	4.81
prostate cancer cell line:PC-3	10439-106E7	23.41	18.33	6.72
prostate, adult, pool1	10022-101D4	8.07	10.70	7.80
putamen, adult, donor10196	10176-103C5	10.15	22.19	18.18
putamen, adult, donor10252	10152-102I8	11.76	13.73	19.61
putamen, adult, donor10258, tech_rep1	10372-105G3	5.46	6.56	6.56
putamen, adult, donor10258, tech_rep2	10372-105G3	7.97	14.50	15.46
putamen, newborn, donor10223	10365-105F5	23.24	9.75	4.50
rectal cancer cell line:TT1TKB	10469-106I1	6.69	3.49	2.33
rectum, fetal, donor1	10067-101I4	30.60	43.12	11.13
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.51	3.82	2.54
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	7.46	19.05	2.07
retina, adult, pool1	10030-101E3	21.87	13.32	16.60
retinoblastoma cell line:Y79	10475-106I7	38.45	48.06	6.50
rhabdomyosarcoma cell line:KYM-1	10787-110H4	5.53	7.99	3.81
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	10.12	15.18	7.31
sacrococcigeal teratoma cell line:HTST	10695-109G2	5.30	11.37	6.06
salivary acinar cells, donor1	11771-123I7	1.94	4.69	3.72
salivary acinar cells, donor2	11772-123I8	4.41	6.75	4.68
salivary acinar cells, donor3	11773-123I9	4.63	11.25	14.57
salivary gland, adult, pool1	10093-102C3	8.01	5.15	5.15
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	7.00	5.14	2.70
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	6.47	7.17	4.23
seminal vesicle, adult	10201-103F3	7.94	10.58	8.47
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.49	15.06	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	24.91	12.33	3.77
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	31.11	11.04	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	20.01	6.85	4.30
signet ring carcinoma cell line:Kato III	10436-106E4	17.13	7.74	4.42
signet ring carcinoma cell line:NUGC-4	10483-107A6	9.93	5.68	5.16
skeletal muscle - soleus muscle, donor1	10282-104F3	2.84	17.02	21.28
skeletal muscle, adult, pool1	10023-101D5	4.44	10.91	16.67
skeletal muscle, fetal, donor1	10066-101I3	8.04	27.14	6.03
skin, adult, donor1	10074-102A2	27.14	0.00	6.79
skin, fetal, donor1	10065-101I2	10.73	41.03	9.47
small cell cervical cancer cell line:HCSC-1	10800-110I8	24.68	14.68	9.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	55.16	49.17	5.99
small cell lung carcinoma cell line:DMS 144	10841-111E4	6.55	30.84	7.32
small cell lung carcinoma cell line:LK-2	10541-107H1	27.03	22.25	5.60
small cell lung carcinoma cell line:NCI-H82	10842-111E5	17.85	49.70	2.57
small cell lung carcinoma cell line:WA-hT	10562-108A4	29.20	13.29	5.01
small intestine, adult, pool1	10024-101D6	11.71	8.72	9.79
small intestine, fetal, donor1	10064-101I1	7.86	18.18	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	58.98	18.98	2.56
smooth muscle, adult, pool1	10048-101G3	2.58	13.18	6.20
somatostatinoma cell line:QGP-1	10781-110G7	13.67	15.55	1.88
spinal cord - adult, donor10196	10181-103D1	16.98	17.21	8.03
spinal cord, adult, donor10252	10159-103A6	14.98	11.83	10.65
spinal cord, adult, donor10258	10369-105F9	8.99	6.92	11.07
spinal cord, fetal, donor1	10056-101H2	16.47	35.98	15.86
spinal cord, newborn, donor10223	10359-105E8	20.21	13.32	8.73
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	5.38	11.35	0.45
spleen, adult, pool1	10025-101D7	18.50	8.70	9.03
spleen, fetal, pool1	10044-101F8	50.53	13.43	10.01
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	24.22	13.15	2.90
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	7.22	6.46	4.75
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	4.89	16.42	8.74
squamous cell carcinoma cell line:T3M-5	10616-108G4	10.95	7.82	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.93	11.71	3.71
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.33	5.93	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	6.35	3.38	0.85
stomach, fetal, donor1	10062-101H8	11.75	38.45	11.75
submaxillary gland, adult	10202-103F4	4.56	11.96	11.39
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	23.06	17.45	15.79
substantia nigra, adult, donor10258	10371-105G2	6.21	10.35	9.83
substantia nigra, newborn, donor10223	10358-105E7	22.61	6.36	7.07
synovial sarcoma cell line:HS-SY-II	10441-106E9	11.00	13.99	8.25
temporal lobe, adult, pool1	10031-101E4	10.51	16.19	17.38
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	38.46	146.73	16.38
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	23.74	54.50	10.99
tenocyte, donor1	11763-123H8	3.14	8.03	4.89
tenocyte, donor2	11765-123I1	6.10	9.16	8.39
tenocyte, donor3	11768-123I4	5.56	8.15	6.67
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	25.32	35.86	3.40
teratocarcinoma cell line:NCR-G1	10798-110I6	12.79	22.97	1.70
teratocarcinoma cell line:PA-1	10807-111A6	11.31	22.32	2.94
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	43.04	19.17	2.16
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.24	20.42	5.29
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	21.49	6.11	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	59.28	52.76	4.89
testis, adult, pool1	10026-101D8	19.97	16.96	28.02
testis, adult, pool2	10096-102C6	42.40	60.45	53.23
thalamus - adult, donor10196	10168-103B6	12.14	18.77	13.25
thalamus, adult, donor10252	10154-103A1	28.13	22.04	15.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	4.62	16.94
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.89	10.38	9.06
thalamus, newborn, donor10223	10366-105F6	10.36	10.93	5.75
throat, adult	10209-103G2	9.49	14.48	8.49
throat, fetal, donor1	10061-101H7	12.49	33.82	10.36
thymic carcinoma cell line:Ty-82	10803-111A2	21.66	19.87	2.58
thymus, adult, pool1	10027-101D9	11.83	18.09	7.06
thymus, fetal, pool1	10043-101F7	44.47	45.20	11.43
thyroid carcinoma cell line:KHM-5M	10776-110G2	10.77	15.96	2.53
thyroid carcinoma cell line:TCO-1	10783-110G9	7.12	11.04	1.40
thyroid, adult, pool1	10028-101E1	7.09	9.52	13.53
thyroid, fetal, donor1	10060-101H6	12.13	28.21	10.02
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	21.56	21.56
tongue, adult	10203-103F5	6.51	9.54	11.63
tongue, fetal, donor1	10059-101H5	5.12	35.07	9.46
tonsil, adult, pool1	10047-101G2	13.72	12.12	10.42
trachea, adult, pool1	10029-101E2	17.59	7.20	5.24
trachea, fetal, donor1	10058-101H4	20.39	26.54	3.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	4.25	6.02	2.83
transitional-cell carcinoma cell line:5637	10418-106C4	26.14	18.74	10.03
transitional-cell carcinoma cell line:JMSU1	10492-107B6	5.01	10.65	1.57
tridermal teratoma cell line:HGRT	10694-109G1	17.12	20.93	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	3.64	9.40	3.56
umbilical cord, fetal, donor1	10057-101H3	8.35	31.30	6.26
uterus, adult, pool1	10100-102D1	5.46	8.53	9.21
uterus, fetal, donor1	10055-101H1	15.87	43.00	5.12
vagina, adult	10204-103F6	12.28	10.99	7.11
vein, adult	10191-103E2	9.64	12.28	10.52
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.21	13.89	2.94